STOCK TITAN

[Form 4] Bruker Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Bruker Corporation (BRKR) reporting person Mark Munch, Executive Vice President & President of Bruker Nano Inc., received equity awards on August 15, 2025. The filing shows 23,631 restricted stock units granted and 22,337 stock options with an exercise price of $33.52. The restricted stock units vest in four equal annual installments beginning one year after the original grant date, and the stock options vest on the same four‑year schedule with an exercisability starting 08/15/2026 and expiration on 08/15/2035. After the reported transactions, Mr. Munch beneficially owns 128,443 common shares and directly holds the 22,337 shares underlying the new options.

Mark Munch, Executive Vice President e Presidente di Bruker Nano Inc., persona segnalante per Bruker Corporation (BRKR), ha ricevuto premi in azioni il 15 agosto 2025. La comunicazione indica la concessione di 23.631 unità di azioni vincolate (RSU) e di 22.337 opzioni su azioni con prezzo di esercizio di $33,52. Le unità di azioni vincolate maturano in quattro rate annuali uguali a partire da un anno dalla data di assegnazione, e le opzioni seguono lo stesso piano di vesting quadriennale con possibilità di esercizio a partire dal 15/08/2026 e scadenza il 15/08/2035. Dopo le operazioni riportate, il sig. Munch possiede economicamente 128.443 azioni ordinarie e detiene direttamente le 22.337 azioni sottostanti alle nuove opzioni.

Mark Munch, vicepresidente ejecutivo y presidente de Bruker Nano Inc., persona informante de Bruker Corporation (BRKR), recibió compensación en acciones el 15 de agosto de 2025. El informe muestra la concesión de 23.631 unidades restringidas de acciones (RSU) y 22.337 opciones sobre acciones con un precio de ejercicio de $33,52. Las unidades restringidas se consolidan en cuatro pagos anuales iguales a partir de un año desde la fecha de concesión, y las opciones siguen el mismo calendario de cuatro años con posibilidad de ejercerse desde el 15/08/2026 y vencimiento el 15/08/2035. Tras las transacciones notificadas, el Sr. Munch posee beneficiariamente 128.443 acciones ordinarias y mantiene directamente las 22.337 acciones subyacentes a las nuevas opciones.

Bruker Corporation(BRKR)의 보고자이자 Bruker Nano Inc.의 부사장 겸 사장인 마크 먼치(Mark Munch)가 2025년 8월 15일 주식 보상을 받았습니다. 제출 서류에 따르면 23,631개의 제한부 주식 단위(RSU)22,337주의 스톡옵션이 부여되었으며 행사가격은 $33.52입니다. 제한부 주식은 최초 부여일로부터 1년 후부터 시작해 4년에 걸쳐 연등분으로 베스팅되며, 스톡옵션도 동일한 4년 일정으로 베스팅되고 2026-08-15부터 행사 가능하며 만료일은 2035-08-15입니다. 보고된 거래 후 먼치 씨는 128,443주의 보통주에 대한 실질적 소유권을 보유하고 있으며 새 옵션의 기초가 되는 22,337주를 직접 보유하고 있습니다.

Mark Munch, vice‑président exécutif et président de Bruker Nano Inc., personne déclarante pour Bruker Corporation (BRKR), a reçu des attributions d’actions le 15 août 2025. le dossier indique l’attribution de 23 631 unités d’actions restreintes (RSU) et de 22 337 options au prix d’exercice de 33,52 $. Les unités d’actions restreintes se libèrent en quatre versements annuels égaux à compter d’un an après la date d’attribution, et les options suivent le même calendrier de quatre ans, exerçables à partir du 15/08/2026 et arrivant à échéance le 15/08/2035. Après les opérations déclarées, M. Munch détient effectivement 128 443 actions ordinaires et possède directement les 22 337 actions sous‑jacentes aux nouvelles options.

Mark Munch, Executive Vice President und Präsident von Bruker Nano Inc. und meldende Person für Bruker Corporation (BRKR), erhielt am 15. August 2025 Aktienzuwendungen. Die Meldung weist 23.631 Restricted Stock Units (RSU) und 22.337 Aktienoptionen mit einem Ausübungspreis von $33,52 aus. Die RSUs vesten in vier gleichen jährlichen Raten, beginnend ein Jahr nach dem ursprünglichen Gewährungsdatum; die Optionen vesten nach demselben Vierjahresplan, sind ab dem 15.08.2026 ausübbar und laufen am 15.08.2035 aus. Nach den gemeldeten Transaktionen besitzt Herr Munch wirtschaftlich 128.443 Stammaktien und hält direkt die 22.337 Aktien, die den neuen Optionen zugrunde liegen.

Positive
  • 23,631 restricted stock units were granted to the reporting officer on 08/15/2025
  • 22,337 stock options were granted with an exercise price of $33.52
  • Vesting for both RSUs and options occurs in four equal annual installments, providing clear timelines
Negative
  • None.

Insights

TL;DR: Executive received time‑vesting RSUs and stock options, a routine compensation event aligning long‑term pay with shareholder value.

This Form 4 documents grants dated 08/15/2025 to an officer: 23,631 restricted stock units and 22,337 options priced at $33.52. Both awards vest in four equal annual installments, with options exercisable beginning 08/15/2026 and expiring 08/15/2035. For compensation assessment, the schedule and size are clear; these are typical long‑term incentive structures rather than immediate cash payouts. The filing is procedural and does not indicate secondary sales or purchases that would change near‑term share supply.

TL;DR: Disclosure is complete for the reported equity awards and complies with Section 16 reporting requirements.

The Form 4 identifies the reporting person, issuer (BRKR), transaction date (08/15/2025), award types, quantities, exercise price for options, vesting schedule, and post‑transaction beneficial ownership totals. The form is signed by an attorney‑in‑fact and includes explanatory notes about vesting. From a compliance standpoint, the filing contains the necessary fields and appears timely and properly executed.

Mark Munch, Executive Vice President e Presidente di Bruker Nano Inc., persona segnalante per Bruker Corporation (BRKR), ha ricevuto premi in azioni il 15 agosto 2025. La comunicazione indica la concessione di 23.631 unità di azioni vincolate (RSU) e di 22.337 opzioni su azioni con prezzo di esercizio di $33,52. Le unità di azioni vincolate maturano in quattro rate annuali uguali a partire da un anno dalla data di assegnazione, e le opzioni seguono lo stesso piano di vesting quadriennale con possibilità di esercizio a partire dal 15/08/2026 e scadenza il 15/08/2035. Dopo le operazioni riportate, il sig. Munch possiede economicamente 128.443 azioni ordinarie e detiene direttamente le 22.337 azioni sottostanti alle nuove opzioni.

Mark Munch, vicepresidente ejecutivo y presidente de Bruker Nano Inc., persona informante de Bruker Corporation (BRKR), recibió compensación en acciones el 15 de agosto de 2025. El informe muestra la concesión de 23.631 unidades restringidas de acciones (RSU) y 22.337 opciones sobre acciones con un precio de ejercicio de $33,52. Las unidades restringidas se consolidan en cuatro pagos anuales iguales a partir de un año desde la fecha de concesión, y las opciones siguen el mismo calendario de cuatro años con posibilidad de ejercerse desde el 15/08/2026 y vencimiento el 15/08/2035. Tras las transacciones notificadas, el Sr. Munch posee beneficiariamente 128.443 acciones ordinarias y mantiene directamente las 22.337 acciones subyacentes a las nuevas opciones.

Bruker Corporation(BRKR)의 보고자이자 Bruker Nano Inc.의 부사장 겸 사장인 마크 먼치(Mark Munch)가 2025년 8월 15일 주식 보상을 받았습니다. 제출 서류에 따르면 23,631개의 제한부 주식 단위(RSU)22,337주의 스톡옵션이 부여되었으며 행사가격은 $33.52입니다. 제한부 주식은 최초 부여일로부터 1년 후부터 시작해 4년에 걸쳐 연등분으로 베스팅되며, 스톡옵션도 동일한 4년 일정으로 베스팅되고 2026-08-15부터 행사 가능하며 만료일은 2035-08-15입니다. 보고된 거래 후 먼치 씨는 128,443주의 보통주에 대한 실질적 소유권을 보유하고 있으며 새 옵션의 기초가 되는 22,337주를 직접 보유하고 있습니다.

Mark Munch, vice‑président exécutif et président de Bruker Nano Inc., personne déclarante pour Bruker Corporation (BRKR), a reçu des attributions d’actions le 15 août 2025. le dossier indique l’attribution de 23 631 unités d’actions restreintes (RSU) et de 22 337 options au prix d’exercice de 33,52 $. Les unités d’actions restreintes se libèrent en quatre versements annuels égaux à compter d’un an après la date d’attribution, et les options suivent le même calendrier de quatre ans, exerçables à partir du 15/08/2026 et arrivant à échéance le 15/08/2035. Après les opérations déclarées, M. Munch détient effectivement 128 443 actions ordinaires et possède directement les 22 337 actions sous‑jacentes aux nouvelles options.

Mark Munch, Executive Vice President und Präsident von Bruker Nano Inc. und meldende Person für Bruker Corporation (BRKR), erhielt am 15. August 2025 Aktienzuwendungen. Die Meldung weist 23.631 Restricted Stock Units (RSU) und 22.337 Aktienoptionen mit einem Ausübungspreis von $33,52 aus. Die RSUs vesten in vier gleichen jährlichen Raten, beginnend ein Jahr nach dem ursprünglichen Gewährungsdatum; die Optionen vesten nach demselben Vierjahresplan, sind ab dem 15.08.2026 ausübbar und laufen am 15.08.2035 aus. Nach den gemeldeten Transaktionen besitzt Herr Munch wirtschaftlich 128.443 Stammaktien und hält direkt die 22.337 Aktien, die den neuen Optionen zugrunde liegen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Munch Mark

(Last) (First) (Middle)
BRUKER CORPORATION
40 MANNING ROAD

(Street)
BILLERICA MA 01821

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BRUKER CORP [ BRKR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EXEC VP&PRES BRUKER NANO INC.
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/15/2025 A 23,631(1) A $0 128,443 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Purchase) $33.52 08/15/2025 A 22,337 08/15/2026(2) 08/15/2035 Common Stock 22,337 $0 22,337 D
Explanation of Responses:
1. The Restricted Stock Units granted to the Reporting Person on August 15, 2025 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
2. The Stock Options granted to the Reporting Person on August 15, 2025 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
/s/ Michael Simone, Attorney-in-Fact 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did BRKR reporting person Mark Munch receive on 08/15/2025?

The filing shows 23,631 restricted stock units and 22,337 stock options granted on 08/15/2025.

What is the exercise price and expiry of the stock options granted to the BRKR officer?

The stock options have an exercise price of $33.52 and expire on 08/15/2035.

When do the RSUs and options vest according to the Form 4?

Both the restricted stock units and the stock options vest in equal installments on each of the first four anniversaries of the original grant date (08/15/2025).

How many BRKR shares does the reporting person beneficially own after the transaction?

Following the reported transactions, the reporting person beneficially owns 128,443 common shares and directly holds the 22,337 shares underlying the new options.

Who signed the Form 4 for the reporting person?

The Form 4 was signed by Michael Simone, Attorney‑in‑Fact on 08/19/2025.
Bruker Corp

NASDAQ:BRKR

BRKR Rankings

BRKR Latest News

BRKR Latest SEC Filings

BRKR Stock Data

5.19B
103.27M
31.91%
83.8%
6.15%
Medical Devices
Laboratory Analytical Instruments
Link
United States
BILLERICA